These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 15790936)

  • 21. Rho kinase, a promising drug target for neurological disorders.
    Mueller BK; Mack H; Teusch N
    Nat Rev Drug Discov; 2005 May; 4(5):387-98. PubMed ID: 15864268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II up-regulates the leukemia-associated Rho guanine nucleotide exchange factor (RhoGEF), a regulator of G protein signaling domain-containing RhoGEF, in vascular smooth muscle cells.
    Ying Z; Jin L; Palmer T; Webb RC
    Mol Pharmacol; 2006 Mar; 69(3):932-40. PubMed ID: 16354763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of aminofurazan-azabenzimidazoles as inhibitors of Rho-kinase with high kinase selectivity and antihypertensive activity.
    Stavenger RA; Cui H; Dowdell SE; Franz RG; Gaitanopoulos DE; Goodman KB; Hilfiker MA; Ivy RL; Leber JD; Marino JP; Oh HJ; Viet AQ; Xu W; Ye G; Zhang D; Zhao Y; Jolivette LJ; Head MS; Semus SF; Elkins PA; Kirkpatrick RB; Dul E; Khandekar SS; Yi T; Jung DK; Wright LL; Smith GK; Behm DJ; Doe CP; Bentley R; Chen ZX; Hu E; Lee D
    J Med Chem; 2007 Jan; 50(1):2-5. PubMed ID: 17201404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of RhoA/Rho-kinase in the regulation of penile erection].
    Xia C; Jiang R
    Zhonghua Nan Ke Xue; 2007 Jun; 13(6):546-9. PubMed ID: 17615983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and synthesis of Rho kinase inhibitors (II).
    Iwakubo M; Takami A; Okada Y; Kawata T; Tagami Y; Ohashi H; Sato M; Sugiyama T; Fukushima K; Iijima H
    Bioorg Med Chem; 2007 Jan; 15(1):350-64. PubMed ID: 17046269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular mechanism involved in arteriosclerosis--the roles of nitric oxide and Rho/Rho-kinase].
    Takeshita A
    Nihon Naika Gakkai Zasshi; 2001 Feb; 90 Suppl():66-70. PubMed ID: 11307337
    [No Abstract]   [Full Text] [Related]  

  • 27. [Rho-kinase inhibitors for ischemic heart disease].
    Mohri M; Shimokawa H
    Nihon Rinsho; 2003 May; 61 Suppl 5():874-9. PubMed ID: 12809048
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of Rho, Rac, and Rho-kinase in phosphorylation of myosin light chain, development of polarity, and spontaneous migration of Walker 256 carcinosarcoma cells.
    Gutjahr MC; Rossy J; Niggli V
    Exp Cell Res; 2005 Aug; 308(2):422-38. PubMed ID: 15950966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proerectile effects of the Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinolinyl)sulfonyl]homopiperazine (H-1152) in the rat penis.
    Teixeira CE; Ying Z; Webb RC
    J Pharmacol Exp Ther; 2005 Oct; 315(1):155-62. PubMed ID: 15976017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thromboxane prostanoid receptor activation impairs endothelial nitric oxide-dependent vasorelaxations: the role of Rho kinase.
    Liu CQ; Leung FP; Wong SL; Wong WT; Lau CW; Lu L; Yao X; Yao T; Huang Y
    Biochem Pharmacol; 2009 Aug; 78(4):374-81. PubMed ID: 19409373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diverse signaling pathways regulate fibroblast differentiation and transformation through Rho kinase activation.
    Harvey KA; Paranavitana CN; Zaloga GP; Siddiqui RA
    J Cell Physiol; 2007 May; 211(2):353-63. PubMed ID: 17167780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Segmental differences in the roles of rho-kinase and protein kinase C in mediating vasoconstriction.
    Budzyn K; Paull M; Marley PD; Sobey CG
    J Pharmacol Exp Ther; 2006 May; 317(2):791-6. PubMed ID: 16452393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of Rho-kinase normalizes nonspecific hyperresponsiveness in passively sensitized airway smooth muscle preparations.
    Schaafsma D; Zuidhof AB; Nelemans SA; Zaagsma J; Meurs H
    Eur J Pharmacol; 2006 Feb; 531(1-3):145-50. PubMed ID: 16451800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Molecular mechanism of arteriosclerosis--the roles of nitric oxide and rho kinase].
    Takeshita A
    Nihon Naika Gakkai Zasshi; 2001 Sep; 90(9):1650-63. PubMed ID: 11681040
    [No Abstract]   [Full Text] [Related]  

  • 35. Nitric oxide and Bartter and Gitelman syndromes.
    Warnock DG
    Kidney Int; 2001 Sep; 60(3):1197-8. PubMed ID: 11532116
    [No Abstract]   [Full Text] [Related]  

  • 36. Blood pressure-independent effects of Rho-kinase inhibitors in the kidney?
    Jan Danser AH
    J Hypertens; 2004 Sep; 22(9):1675-7. PubMed ID: 15311093
    [No Abstract]   [Full Text] [Related]  

  • 37. [Bartter syndrome--case report].
    Daniluk U; Kaczmarski M; Wasilewska J; Matuszewska E; Semeniuk J; Sidor K; Krasnow A
    Pol Merkur Lekarski; 2004 Apr; 16(94):375-7. PubMed ID: 15517937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Five-case report of Bartter syndrome].
    Tan XF; Li WX; Hu M
    Hunan Yi Ke Da Xue Xue Bao; 2000 Apr; 25(2):112, 116. PubMed ID: 12212191
    [No Abstract]   [Full Text] [Related]  

  • 39. Comment on: Bartter syndrome and cholelithiasis in an infant: is this a mere coincidence? (Eur J Pediatr 2008;167(1):109-110).
    Shin JI; Lee JS
    Eur J Pediatr; 2009 Mar; 168(3):371-2; author reply 373-4. PubMed ID: 18670788
    [No Abstract]   [Full Text] [Related]  

  • 40. Angiotensin II and Cardiovascular-Renal Remodelling in Hypertension: Insights from a Human Model Opposite to Hypertension.
    Ravarotto V; Pagnin E; Fragasso A; Maiolino G; Calò LA
    High Blood Press Cardiovasc Prev; 2015 Sep; 22(3):215-23. PubMed ID: 25759028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.